SCHEMBL1122576

SCHEMBL1122576

COC(=O)[C@H](Cc1ccc(OCc2ccccc2)cc1)NC(=O)c1ccc(OCc2cccc(C)c2)cc1

nearest known ligand 0.68

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.68
RAB9A P51151 1/20 0.68
PPARG P37231 1/20 0.60
ERAP2 Q6P179 1/20 0.59
LNPEP Q9UIQ6 1/20 0.59
YAP1 P46937 3/20 0.59
PTPN1 P18031 2/20 0.57
GPR132 Q9UNW8 2/20 0.56
POLB P06746 1/20 0.56
NR1H4 Q96RI1 1/20 0.55
MAOB P27338 1/20 0.55
ALDH1A1 P00352 2/20 0.53
MEN1 O00255 1/20 0.53
LMNA P02545 1/20 0.53
KMT2A Q03164 1/20 0.53
LTA4H P09960 1/20 0.52
FFAR1 O14842 1/20 0.51
CTSB P07858 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27658923 1.00 GAA (0.68) GAARAB9APPARGERAP2LNPEP
SCHEMBL6029421 0.95 GAA (0.67) GAARAB9APPARGERAP2LNPEP
SCHEMBL1122951 0.92 GPR132 (0.67) GAARAB9APPARGPTPN1GPR132
SCHEMBL1123382 0.92 GAA (0.71) GAARAB9APPARGERAP2LNPEP
SCHEMBL28760295 0.92 GPR132 (0.67) GAARAB9APPARGPTPN1GPR132
SCHEMBL1123055 0.92 GAA (0.80) GAARAB9APPARGERAP2LNPEP
SCHEMBL1122839 0.90 GAA (0.68) GAARAB9APPARGERAP2LNPEP
SCHEMBL1123063 0.89 GAA (0.67) GAARAB9APPARGERAP2LNPEP
SCHEMBL1123173 0.89 GAA (0.67) GAARAB9APPARGERAP2LNPEP
SCHEMBL1123642 0.89 GAA (0.67) GAARAB9APPARGERAP2LNPEP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1644321-B1 NEW BENZAMIDES AS PPATY MODULATORS S A L V A T LAB SA (ES) 2011-02-09 EP claimed
US-20060160894-A1 Benzamides as ppar modulators LABORATORIOS S.A.L.V.A.T.,S.A. (ES) 2006-07-20 US claimed
EP-1644321-B1 NEW BENZAMIDES AS PPATY MODULATORS S A L V A T LAB SA (ES) 2011-02-09 EP disclosed
US-20060160894-A1 Benzamides as ppar modulators LABORATORIOS S.A.L.V.A.T.,S.A. (ES) 2006-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160894-A1 Benzamides as ppar modulators PPARD, PPARA, PPARG GAA 3048/4885RAB9A 4567/4885PPARG 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.